Lifecore Biomedical, Inc. (LFCR) Q4 2024 Earnings Call

Investor webinar replay

Replay transcript excerpt

and thank you for joining LifeCorps' fiscal 2025 fourth quarter and full year earnings call. During the call, all participants will be in a listen-only mode. Now, I would like to turn the call over to Stephanie Diaz, Manager of Investor Relations for LifeCorps. Please go ahead. Good afternoon, and thank you for joining us today to discuss LifeCorps Biomedical's fourth quarter and full year fiscal 2025 earnings results. Hosting the call today from LifeCorps are Paul Josephs, President and Chief Executive Officer, and Ryan Lake, Chief Financial Officer. Before we begin today, we'd like to remind everyone that certain statements made in the course of this conference call contain forward-looking statements. It is important to note that the forward-looking statements made during this call reflect management's judgment and analysis only as of today, August 7, 2025, and the company's actual results could differ materially from those projected in such forward-looking statements. For a more thorough discussion of the risks and uncertainties associated with any forward-looking statements, please see the disclaimer regarding forward-looking statements that is included in our fourth quarter and fiscal year 2025 earnings press release, which was furnished to the SEC today on Form 8K and is available on our corporate website at lifecore.com. as well as our other filings with the Securities and Exchange Commission, including but not limited to the company's Form 10-K for the fiscal year ended May 25, 2025, which was filed this afternoon and is also available on our website. In addition, our earnings press release includes a discussion of, and during this call we will reference, certain non-GAAP information. You can find relevant non-GAAP reconciliations in our earnings press releas...